Emergent BioSolutions Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Emergent BioSolutions Inc. for March 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 13,237 | 0 | 48,598 | |
Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 51.84 | 3,224 | 167,132 | 1,554,993 | 1.6 M to 1.6 M (-0.21 %) |
Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 13,237 | 0 | 1,558,217 | 1.5 M to 1.6 M (+0.86 %) |
Mar 13 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Payment of Exercise | F | 51.84 | 1,727 | 89,528 | 89,879 | 91.6 K to 89.9 K (-1.89 %) |
Mar 13 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 52.82 | 5,842 | 308,574 | 29,914 | 35.8 K to 29.9 K (-16.34 %) |
Mar 13 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 51.84 | 974 | 50,492 | 35,756 | 36.7 K to 35.8 K (-2.65 %) |
Mar 13 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 51.84 | 7,825 | 405,648 | 213,128 | 221 K to 213.1 K (-3.54 %) |
Mar 09 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 22.03 | 6,573 | 144,803 | 0 | |
Mar 09 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 50.43 | 2,843 | 143,372 | 36,730 | 39.6 K to 36.7 K (-7.18 %) |
Mar 09 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 22.03 | 6,573 | 144,803 | 39,573 | 33 K to 39.6 K (+19.92 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,723 | 0 | 61,835 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 71,558 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 49.64 | 38,577 | 1,914,962 | 38,577 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 19,288 | 0 | 81,352 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 49.97 | 2,368 | 118,329 | 1,544,980 | 1.5 M to 1.5 M (-0.15 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,723 | 0 | 1,547,348 | 1.5 M to 1.5 M (+0.63 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 49.64 | 2,385 | 118,391 | 1,537,625 | 1.5 M to 1.5 M (-0.15 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,540,010 | 1.5 M to 1.5 M (+0.64 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | A | 49.64 | 20,145 | 999,998 | 20,145 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 49.50 | 1,898 | 93,951 | 33,000 | 34.9 K to 33 K (-5.44 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 49.97 | 811 | 40,526 | 34,898 | 35.7 K to 34.9 K (-2.27 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 49.64 | 409 | 20,303 | 35,709 | 36.1 K to 35.7 K (-1.13 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,036 | 0 | 36,118 | 31.1 K to 36.1 K (+16.20 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,036 | 0 | 31,082 | 26 K to 31.1 K (+19.34 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Option Exercise | A | 49.64 | 21,253 | 1,054,999 | 21,253 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,313 | 0 | 23,440 | 18.1 K to 23.4 K (+29.31 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,313 | 0 | 18,127 | 12.8 K to 18.1 K (+41.46 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Option Exercise | A | 49.64 | 16,116 | 799,998 | 16,116 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 49.97 | 540 | 26,984 | 17,071 | 17.6 K to 17.1 K (-3.07 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 49.64 | 387 | 19,211 | 17,611 | 18 K to 17.6 K (-2.15 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,029 | 0 | 17,998 | 14 K to 18 K (+28.84 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 4,029 | 0 | 13,969 | 9.9 K to 14 K (+40.53 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Option Exercise | A | 49.64 | 23,670 | 1,174,979 | 23,670 | |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Payment of Exercise | F | 49.97 | 1,545 | 77,204 | 91,606 | 93.2 K to 91.6 K (-1.66 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Payment of Exercise | F | 49.64 | 778 | 38,620 | 93,151 | 93.9 K to 93.2 K (-0.83 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Grant | A | 0.00 | 5,917 | 0 | 93,929 | 88 K to 93.9 K (+6.72 %) |
Mar 01 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Grant | A | 0.00 | 5,917 | 0 | 88,012 | 82.1 K to 88 K (+7.21 %) |